ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01258634
Recruitment Status : Terminated (PI no longer affiliated with institution; only 2 subjects enrolled)
First Posted : December 13, 2010
Last Update Posted : December 10, 2013
Sponsor:
Information provided by (Responsible Party):
University of Chicago

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2011
  Actual Study Completion Date : November 2011